Announcements Trials

Browse Landscape

Sponsor

Conditions

Tuberous Sclerosis 3 Seizures 3 Sturge-Weber Syndrome 2 Tuberous Sclerosis 2 1 Tuberous Sclerosis 1 1 Spasms, Infantile 1 Lennox Gastaut Syndrome 1 Glioblastoma 1 Epilepsy 1 Epilepsies, Myoclonic 1 Drug Resistant Epilepsy 1 Cognitive Dysfunction 1 Chemotherapy-Induced Peripheral Neuropathy 1 Breast Neoplasms 1 Arthralgia 1 Anxiety Disorders 1

Interventions

Leucovorin 38 Fluorouracil 36 Oxaliplatin 34 Bevacizumab 34 Irinotecan 32 Cetuximab 23 Capecitabine 18 Panitumumab 14 IFL protocol 7 Folfox protocol 6 Celecoxib 6 Radiotherapy 5 Nivolumab 5 Magnetic Resonance Spectroscopy 5 Immunohistochemistry 5 Gene Expression Profiling 5 regorafenib 4 pembrolizumab 4 dehydroftorafur 4 Ramucirumab 4 Fluorodeoxyglucose F18 4 Floxuridine 4 aflibercept 3 Surgical Procedures, Operative 3 Sorafenib 3 Radiosurgery 3 Ipilimumab 3 Gemcitabine 3 Fentanyl 3 Drug Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Colonic Neoplasms × Cannabidiol × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡